Doe v. Miles Inc.

945 P.2d 1304, 190 Ariz. 173
CourtCourt of Appeals of Arizona
DecidedNovember 14, 1997
Docket2 CA-CV 96-0166, 2 CA-CV 96-0167
StatusPublished
Cited by2 cases

This text of 945 P.2d 1304 (Doe v. Miles Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals of Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Doe v. Miles Inc., 945 P.2d 1304, 190 Ariz. 173 (Ark. Ct. App. 1997).

Opinion

OPINION

PELANDER, Presiding Judge.

In these consolidated actions, plaintiffs/appellants Jane Doe and her son, A. Doe, contend the trial court erred in granting summary judgment for defendants/appellees on statute of limitations grounds. We disagree and therefore affirm.

We view the evidence in the light most favorable to the parties against whom summary judgment was entered and independently review any questions of law relating to the statute of limitations defense. Owens v. City of Phoenix, 180 Ariz. 402, 405, 884 P.2d 1100, 1103 (App.1994); Zuck v. State, 159 Ariz. 37, 39, 764 P.2d 772, 774 (App.1988). Jane Doe’s twin sons, A. Doe and B. Doe, were diagnosed with mild hemophilia shortly after their births in 1969. 1 Their medically-prescribed treatment from 1978 to 1987 included infusion of “factor VIII concentrate,” 2 a blood coagulant used to control and stop bleeding in hemophiliacs. Both A. and B. contracted human immunodeficiency virus (HIV) from the factor concentrate infusions. B. tested positive for HIV in July 1987 and ultimately died of acquired immune deficiency syndrome (AIDS) in April 1989. A. also was diagnosed with HIV after testing positive in August 1987. 3

In July 1993, plaintiffs Jane Doe (on behalf of herself and B. Doe’s estate) and A. *175 Doe filed separate actions against defendants/appellees — various producers of factor concentrates (“fractionators”) and healthcare providers who allegedly were involved in the hemophilia care of A. and B. Plaintiffs alleged negligence and product liability theories against the various defendants. Defendants eventually moved for summary judgment on the basis that plaintiffs’ claims were time-barred under A.R.S. § 12-542. The trial court granted the motions, and this appeal followed.

We must determine de novo whether there are any genuine issues of material fact relating to the limitations defense and whether the trial court erred in applying the law. United Bank v. Allyn, 167 Ariz. 191, 805 P.2d 1012 (App.1990). Section 12-542 required that plaintiffs’ actions be “commenced and prosecuted within two years after the cause of action accrue[d], and not afterward.” Under the common law “discovery rule,” a cause of action accrues “when the plaintiff knew or by the exercise of reasonable diligence should have known of the defendants’ conduct and therefore the statute of limitations does not begin to run until that time.” Mayer v. Good Samaritan Hosp., 14 Ariz.App. 248, 252, 482 P.2d 497, 501 (1971). See also Vega v. Morris, 184 Ariz. 461, 463, 910 P.2d 6, 8 (1996). In other words, “the claim is barred two years from when the plaintiff knew or should have known facts giving rise to the claim.” Anson v. American Motors Corp., 155 Ariz. 420, 424, 747 P.2d 581, 585 (App.1987).

Plaintiffs had the burden of establishing that the discovery rule applied to delay the statute of limitations. Ulibarri v. Gerstenberger, 178 Ariz. 151, 155, 871 P.2d 698, 702 (App.1993); Cooney v. Phoenix Newspapers, Inc., 160 Ariz. 139, 141, 770 P.2d 1185, 1187 (App.1989). “Once the defendant has established a prima facie case entitling him to summary judgment [on a statute of limitations defense], the plaintiff has the burden of showing available, competent evidence that would justify a trial.” Ulibarri, 178 Ariz. at 156, 871 P.2d at 703. Plaintiffs failed to sustain that burden here.

The record shows that in 1987, when both A. and B. tested positive for and were diagnosed with HIV, Jane Doe believed they had contracted the virus from factor concentrates. As early as 1983, she also had received, read and retained newsletters and special bulletins which informed her of the link between factor concentrate and HIV/ AIDS. Similarly, A. Doe “firmly believed [as of August 1987] that the only possible source of [his] HIV infection was factor concentrate” he had received through infusions. Both Jane and A. attributed B.’s death to AIDS resulting from his HIV, which they in turn linked to the factor concentrate. A. realized at that time that HIV could lead to AIDS, which could kill him. Finally, plaintiffs knew in 1987 of the healthcare provider/defendants’ role in A.’s and B.’s hemophilia care and either knew or easily could have discovered who had produced, distributed-and supplied the factor concentrates.

Notwithstanding those undisputed facts, plaintiffs contend their cause of action did not accrue until late 1992, when A. Doe first “saw documents” at a National Hemophilia Foundation meeting and “heard from people that there was reason to believe that the fractionators were negligent with regard to transmission of HIV.” 4 It was at that meeting and when he later received additional documents that A. “came to the conclusion that — that there was something wrong.” Similarly, before 1992, Jane Doe was unaware of any wrongdoing associated with hemophiliacs becoming infected with HIV after infusion of factor products or that they may have been “defective.”

According to plaintiffs, a cause of action for medical negligence does not accrue until the plaintiff knows of, or “reasonably should suspect,” defendant’s fault, i.e., negligence, breach of duty or other tortious wrongdoing. Because plaintiffs did not realize that defen *176 dants were negligent or otherwise at fault until 1992, they contend filing their suits in July 1993 was timely. We disagree. Accepting plaintiffs’ proposition would essentially gut the statute of limitations defense. If commencement of the limitations period depended on a plaintiffs subjectively and fortuitously “discovering” or “realizing” a putative defendant’s fault, even long after the plaintiff knew the facts about that defendant’s identity and relationship to plaintiff, plaintiffs injury and causation, the defense would be virtually meaningless.

As Division One of this court has stated:

[A] cause of action “accrues” when the plaintiff discovers or by the exercise of reasonable diligence should have discovered that he or she has been injured by a particular defendant’s negligent conduct. The cause of action does not accrue until the plaintiff knows or' should have known of both the what and who elements of causation.

Lawhon v. L.B.J. Institutional Supply, Inc.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jane Doe One v. Garcia
5 F. Supp. 2d 767 (D. Arizona, 1998)
Pallen v. United Parcel Service General Services Co.
997 F. Supp. 1367 (D. Oregon, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
945 P.2d 1304, 190 Ariz. 173, Counsel Stack Legal Research, https://law.counselstack.com/opinion/doe-v-miles-inc-arizctapp-1997.